Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
Sam SollieDominique S MichaudDebashis SarkerSophia N KaragiannisDebra H JosephsNiklas HammarAida SantaolallaGoran WalldiusHans GarmoLars HolmbergIngmar JungnerMieke Van HemelrijckPublished in: BMC cancer (2019)
We found an increased risk of pancreatic cancer associated with pre-diagnostic serum levels of haptoglobin, CRP and leukocytes. Our finding suggests a possible role of chronic inflammation in the aetiology of pancreatic cancer and highlight the need to further investigate this association.